Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CURI | Common Stock | Options Exercise | +104 | +0.26% | 39.5K | Jul 28, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CURI | Restricted Stock Units | Award | +56.6K | 56.6K | Jul 28, 2023 | Common Stock | 4.76K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Represents the vesting of restricted stock units ("RSUs") into 104 shares of the Company's common stock immediately upon the Company's cancellation of certain "underwater" stock options granted to employees and executive officers and replacement thereof with RSUs on July 28, 2023, the vesting of which was inadvertently omitted from the Form 4 filed by Ms. Cudahy on August 1, 2023. Each RSU represents a contingent right to receive one share of common stock. The remaining unvested RSUs granted will vest as follows: 7,902 shares on August 2, 2023; 1,406 shares in equal increments every third month beginning September 25, 2023 through March 25, 2025; 2,711 shares in equal increments every month beginning August 20, 2023 through September 20, 2025; and 44,556 shares on January 1, 2025. |
F2 | The Compensation Committee of the Board of Directors of the Company approved the cancellation of Ms. Cudahy's options to purchase 613,434 shares of common stock, granted under the Company's 2020 Omnibus Incentive Plan, and granted her RSUs of approximately equal fair value of the cancelled stock options, valued as of July 14, 2023. |